Citigroup analysts initiated coverage on AstraZeneca PLC (NASDAQ:AZN) with a Buy rating on January 27, 2026.
AstraZeneca PLC operates in the Healthcare sector. The stock currently trades at $93.22 with a market capitalization of $279.9B.
Citigroup analysts initiated coverage on AstraZeneca PLC (NASDAQ:AZN) with a Buy rating on January 27, 2026. AstraZeneca PLC operates in the Healthcare sector. The stock currently…

Citigroup analysts initiated coverage on AstraZeneca PLC (NASDAQ:AZN) with a Buy rating on January 27, 2026.
AstraZeneca PLC operates in the Healthcare sector. The stock currently trades at $93.22 with a market capitalization of $279.9B.
Current market data
NASDAQ · AZN
$160.17
Up: +$0.53 · +0.33%
Live quote updated
Keep reading
institutional ·
institutional ·
dividends ·
institutional ·